Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Regele

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Clinical Transplants|June 24, 2011
Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case reportElisabeth Schwaiger, Heinz Regele, Markus Wahrmann, et al.
Transplantation|April 7, 2007
Determinants of the complement-fixing ability of recipient presensitization against HLA antigensGregor Bartel, Markus Wahrmann, Markus Exner, et al.
Kidney International|December 1, 2004
Overexpression of HSP-72 confers cytoprotection in experimental peritoneal dialysisBettina Bidmon, Michaela Endemann, Klaus Arbeiter, et al.
Journal of the American Society of Nephrology : JASN|February 17, 2006
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantationGeorg Heinze, Christa Mitterbauer, Heinz Regele, et al.
Transplantation|July 29, 2004
HSP-72 expression in pre-transplant donor kidney biopsies and post-transplant outcomeThomas Mueller, Heinz Regele, Martin Posch, et al.
Transplantation|July 26, 2019
Tubular Ectasia in Renal Allograft Biopsy: Associations With Occult Obstructive Urological ComplicationsMarija Bojić, Heinz Regele, Harald Herkner, et al.
Transplantation|March 21, 2013
miRNA profiling discriminates types of rejection and injury in human renal allograftsJulia Wilflingseder, Heinz Regele, Paul Perco, et al.
Frontiers in Immunology|December 26, 2022
Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimenLukas W Unger, Moritz Muckenhuber, Benedikt Mahr, et al.
Transplantation|March 3, 2017
Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft InjuryNicolas Kozakowski, Farsad Eskandary, Harald Herkner, et al.
Transplantation|March 24, 2005
Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipientsMatthias Lorenz, Heinz Regele, Martin Schillinger, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Clinical Transplants|June 24, 2011
Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case reportElisabeth Schwaiger, Heinz Regele, Markus Wahrmann, et al.
Transplantation|April 7, 2007
Determinants of the complement-fixing ability of recipient presensitization against HLA antigensGregor Bartel, Markus Wahrmann, Markus Exner, et al.
Kidney International|December 1, 2004
Overexpression of HSP-72 confers cytoprotection in experimental peritoneal dialysisBettina Bidmon, Michaela Endemann, Klaus Arbeiter, et al.
Journal of the American Society of Nephrology : JASN|February 17, 2006
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantationGeorg Heinze, Christa Mitterbauer, Heinz Regele, et al.
Transplantation|July 29, 2004
HSP-72 expression in pre-transplant donor kidney biopsies and post-transplant outcomeThomas Mueller, Heinz Regele, Martin Posch, et al.
Transplantation|July 26, 2019
Tubular Ectasia in Renal Allograft Biopsy: Associations With Occult Obstructive Urological ComplicationsMarija Bojić, Heinz Regele, Harald Herkner, et al.
Transplantation|March 21, 2013
miRNA profiling discriminates types of rejection and injury in human renal allograftsJulia Wilflingseder, Heinz Regele, Paul Perco, et al.
Frontiers in Immunology|December 26, 2022
Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimenLukas W Unger, Moritz Muckenhuber, Benedikt Mahr, et al.
Transplantation|March 3, 2017
Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft InjuryNicolas Kozakowski, Farsad Eskandary, Harald Herkner, et al.
Transplantation|March 24, 2005
Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipientsMatthias Lorenz, Heinz Regele, Martin Schillinger, et al.
Pageof 15